Phraxis Obtains $1,500,000 New Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ba3f0b5c-aa15-428c-89d8-ee5d4ea6a1c2&Preview=1 -
Date
12/21/2012 -
Company Name
Phraxis -
Mailing Address
2910 13th Terrace NW St. Paul, MN 55112 -
Company Description
Phraxis, Inc. is an early stage medical device company founded to develop novel treatment solutions for patients who need vascular access to enable hemodialysis. Phraxis, Inc.’s first product for commercialization, the InterGraft, will be a percutaneously delivered arterio-venous shunt that provides a unique, non-surgical approach for patients who need vascular access. -
Website
http://www.phraxis.com -
Transaction Type
Venture Equity -
Transaction Amount
$1,500,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
